Improving toxicology testing protocols using computer simulations.
暂无分享,去创建一个
[1] J. Young,et al. PHARMACOKINETICS OF INHALED OR INTRAPERITONEALLY ADMINISTERED STYRENE IN RATS , 1979 .
[2] S. Safe,et al. Comparative toxicology and mechanism of action of polychlorinated dibenzo-p-dioxins and dibenzofurans. , 1986, Annual review of pharmacology and toxicology.
[3] H J Clewell,et al. Biologically motivated models for chemical risk assessment. , 1989, Health physics.
[4] M E Andersen,et al. The acute toxicity of perfluorooctanoic and perfluorodecanoic acids in male rats and effects on tissue fatty acids. , 1983, Toxicology and applied pharmacology.
[5] M E Andersen,et al. Determining kinetic constants of chlorinated ethane metabolism in the rat from rates of exhalation. , 1989, Toxicology and applied pharmacology.
[6] F. A. Smith,et al. Physiologically based pharmacokinetics and the risk assessment process for methylene chloride. , 1987, Toxicology and applied pharmacology.
[7] E. Glover,et al. [125I]2-iodo-3,7,8-trichlorodibenzo-p-dioxin-binding species in mouse liver induced by agonists for the Ah receptor: characterization and identification. , 1989, Molecular pharmacology.
[8] M E Andersen,et al. Physiological model for tissue glutathione depletion and increased resynthesis after ethylene dichloride exposure. , 1988, The Journal of pharmacology and experimental therapeutics.
[9] M E Andersen,et al. A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans. , 1984, Toxicology and applied pharmacology.
[10] J. Young,et al. Pharmacokinetics of inhaled styrene in human volunteers. , 1980, Toxicology and applied pharmacology.
[11] M E Andersen,et al. Partition coefficients of low-molecular-weight volatile chemicals in various liquids and tissues. , 1989, Toxicology and applied pharmacology.
[12] H J Clewell,et al. Metabolism of inhaled dihalomethanes in vivo: differentiation of kinetic constants for two independent pathways. , 1986, Toxicology and applied pharmacology.
[13] J. Huff,et al. Comparative toxicity and carcinogenicity of two chlorinated paraffins in F344/N rats and B6C3F1 mice. , 1987, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[14] M. Andersen,et al. Inhalation pharmacokinetics: evaluating systemic extraction, total in vivo metabolism, and the time course of enzyme induction for inhaled styrene in rats based on arterial blood:inhaled air concentration ratios. , 1984, Toxicology and applied pharmacology.
[15] F D Griffith,et al. Animal toxicity studies with ammonium perfluorooctanoate. , 1980, American Industrial Hygiene Association journal.
[16] R W D'Souza,et al. Physiological Pharmacokinetic Models: Some Aspects of Theory, Practice and Potential , 1988, Toxicology and industrial health.
[17] M E Andersen,et al. Incorporation of in vitro enzyme data into the physiologically-based pharmacokinetic (PB-PK) model for methylene chloride: implications for risk assessment. , 1988, Toxicology letters.
[18] M E Andersen,et al. Toxic effects of nonadecafluoro-n-decanoic acid in rats. , 1986, Toxicology and applied pharmacology.
[19] H J Clewell,et al. A physiologically based simulation approach for determining metabolic constants from gas uptake data. , 1986, Toxicology and applied pharmacology.
[20] E. Glover,et al. Stimulation of in vivo hepatic uptake and in vitro hepatic binding of [125I]2-lodo-3,7,8-trichlorodibenzo-p-dioxin by the administration of agonist for the Ah receptor. , 1989, Molecular pharmacology.
[21] T. Gasiewicz,et al. Cytosolic receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin. Evidence for a homologous nature among various mammalian species. , 1984, Molecular pharmacology.
[22] R K Jain,et al. Physiologically based pharmacokinetic modeling: principles and applications. , 1983, Journal of pharmaceutical sciences.
[23] Vera Fiserova-Bergerova,et al. Determination and prediction of tissue-gas partition coefficients , 1986, International archives of occupational and environmental health.
[24] D J Paustenbach,et al. A physiologically based pharmacokinetic model for 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J and DBA/2J mice. , 1988, Toxicology letters.
[25] D J Paustenbach,et al. A physiologically based pharmacokinetic model for inhaled carbon tetrachloride. , 1988, Toxicology and applied pharmacology.
[26] G. Lucier,et al. Dioxin in soil: bioavailability after ingestion by rats and guinea pigs. , 1984, Science.
[27] D J Paustenbach,et al. A physiological pharmacokinetic description of the tissue distribution and enzyme-inducing properties of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rat. , 1990, Toxicology and applied pharmacology.
[28] M. Andersen,et al. Integration of Pharmacokinetics and Pathological Data in Dose Selection for Chronic Bioassays , 1988 .
[29] H J Clewell,et al. Pharmacokinetics, biochemical mechanism and mutation accumulation: a comprehensive model of chemical carcinogenesis. , 1988, Toxicology letters.
[30] M E Andersen,et al. Modeling the tissue solubilities and metabolic rate constant (Vmax) of halogenated methanes, ethanes, and ethylenes. , 1988, Toxicology letters.
[31] J. Q. Rose,et al. The fate of 2,3,7,8-tetrachlorodibenzo-p-dioxin following single and repeated oral doses to the rat. , 1976, Toxicology and applied pharmacology.
[32] D. M. Hetrick,et al. Pharmacokinetics of tetrachloroethylene. , 1988, Toxicology and applied pharmacology.
[33] M. Andersen,et al. Risk Assessment Extrapolations and Physiological Modeling , 1985, Toxicology and industrial health.
[34] H. Matthews,et al. Pharmacokinetics of PCBs , 1984 .
[35] M. Andersen,et al. Physiologically based pharmacokinetic model for vinylidene chloride. , 1988, Toxicology and applied pharmacology.
[36] R H Reitz,et al. In vitro metabolism of methylene chloride in human and animal tissues: use in physiologically based pharmacokinetic models. , 1989, Toxicology and applied pharmacology.
[37] S. Aust,et al. Specific binding of polyhalogenated aromatic hydrocarbon inducers of cytochrome P-450d to the cytochrome and inhibition of its estradiol 2-hydroxylase activity. , 1987, Toxicology and applied pharmacology.